Wealth Alliance’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,495
Closed -$252K 546
2024
Q2
$252K Sell
8,495
-32
-0.4% -$888 0.03% 431
2024
Q1
$257K Buy
8,527
+513
+6% +$14.2K 0.03% 436
2023
Q4
$229K Sell
8,014
-358
-4% -$10.5K 0.03% 455
2023
Q3
$310K Buy
8,372
+294
+4% +$11.2K 0.05% 339
2023
Q2
$315K Sell
8,078
-455
-5% -$17.8K 0.05% 365
2023
Q1
$312K Sell
8,533
-61
-0.7% -$1.93K 0.05% 350
2022
Q4
$265K Buy
+8,594
New +$267K 0.05% 382

Other funds holding RTO

Wealth Alliance's RTO Position: Q3 2024 in Review

Wealth Alliance sold out of Rentokil (RTO) in Q3 2024, closing a stake of 8,495 shares — an estimated $252K sold.

Wealth Alliance first reported a position in RTO in Q4 2022 and held it in 7 quarters. The position peaked at $315K in Q2 2023. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

  • Wealth Alliance reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
  • Wealth Alliance sold 8,495 Rentokil shares in Q3 2024, an estimated $252K.
  • Wealth Alliance first reported a position in Rentokil in Q4 2022 and held it in 7 quarters.
  • Wealth Alliance's Rentokil position peaked at $315K in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on Wealth Alliance's 13F filing for Q3 2024, filed 4 Nov 2024.